Xtant Medical Holdings Files Definitive Proxy Statement
Ticker: XTNT · Form: DEF 14A · Filed: Jun 10, 2024 · CIK: 1453593
| Field | Detail |
|---|---|
| Company | Xtant Medical Holdings, Inc. (XTNT) |
| Form Type | DEF 14A |
| Filed Date | Jun 10, 2024 |
| Risk Level | low |
| Pages | 16 |
| Reading Time | 19 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, disclosure, corporate-governance
TL;DR
Xtant Medical Holdings filed its proxy statement. Standard shareholder meeting stuff.
AI Summary
Xtant Medical Holdings, Inc. filed a Definitive Proxy Statement (DEF 14A) on June 10, 2024. The filing concerns the company's proxy materials, indicating it is a standard disclosure for shareholder meetings. The company was formerly known as Bacterin International Holdings, Inc. and K KITZ INC.
Why It Matters
This filing is a routine disclosure required for public companies to inform shareholders about matters to be voted on at their annual meeting, impacting corporate governance and shareholder rights.
Risk Assessment
Risk Level: low — This is a routine DEF 14A filing, which is a standard disclosure document for public companies and does not inherently present new risks.
Key Players & Entities
- Xtant Medical Holdings, Inc. (company) — Registrant
- Bacterin International Holdings, Inc. (company) — Former Company Name
- K KITZ INC (company) — Former Company Name
- 20240610 (date) — Filing Date
FAQ
What is the purpose of a DEF 14A filing?
A DEF 14A filing, or Definitive Proxy Statement, is used by companies to solicit proxies from shareholders for an upcoming meeting, providing detailed information about matters to be voted upon.
When was this DEF 14A filed by Xtant Medical Holdings, Inc.?
This DEF 14A filing was filed on June 10, 2024.
What were Xtant Medical Holdings, Inc.'s previous names?
Xtant Medical Holdings, Inc. was formerly known as Bacterin International Holdings, Inc. and K KITZ INC.
Where is Xtant Medical Holdings, Inc. headquartered?
Xtant Medical Holdings, Inc.'s business and mailing address is 664 Cruiser Lane, Belgrade, MT 59714.
What is the Standard Industrial Classification (SIC) code for Xtant Medical Holdings, Inc.?
The SIC code for Xtant Medical Holdings, Inc. is 2836, which falls under Biological Products (No Diagnostic Substances).
Filing Stats: 4,789 words · 19 min read · ~16 pages · Grade level 12.9 · Accepted 2024-06-10 07:00:27
Filing Documents
- formdef14a.htm (DEF 14A) — 638KB
- formdef14a_001.jpg (GRAPHIC) — 3KB
- formdef14a_002.jpg (GRAPHIC) — 1KB
- formdef14a_003.jpg (GRAPHIC) — 2KB
- formdef14a_009.jpg (GRAPHIC) — 1KB
- formdef14a_004.jpg (GRAPHIC) — 40KB
- formdef14a_005.jpg (GRAPHIC) — 28KB
- formdef14a_007.jpg (GRAPHIC) — 94KB
- formdef14a_008.jpg (GRAPHIC) — 78KB
- formdef14a_006.jpg (GRAPHIC) — 4KB
- proxycard_001.jpg (GRAPHIC) — 185KB
- proxycard_002.jpg (GRAPHIC) — 137KB
- 0001493152-24-023268.txt ( ) — 1431KB
EXECUTIVE COMPENSATION
EXECUTIVE COMPENSATION 23 Executive Officers 23 Overview 24 Compensation Philosophy 24 Use of Market Data 24 Elements of Our Executive Compensation Program 25 Summary Compensation Table 26 Executive Employment and Other Agreements 27 401(k) Retirement Plan 27 Outstanding Equity Awards at Fiscal Year-End 28 Xtant Medical Holdings, Inc. 2023 Equity Incentive Plan 29 Potential Payments upon Termination or Change in Control 30 Pay Versus Performance Disclosure 31 TRANSACTIONS WITH RELATED PERSONS, PROMOTERS, AND CERTAIN CONTROL PERSONS 36 Policies and Procedures for Review and Approval of Related Party Transactions 36 Related Party Transactions 36 Family Relationships 37 ii
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 38 Significant Beneficial Owners 38
Security Ownership of Management
Security Ownership of Management 39 Clawback Policy 39 Anti-Hedging and Pledging Policy 39 ADDITIONAL INFORMATION 40 Stockholder Proposals and Director Nominations 40 Householding Information 40 Copies of 2023 Annual Report 40 References in this proxy statement to: “Xtant,” “we,” “us,” “our,” or the “Company” refer to Xtant Medical Holdings, Inc.; “Board” refers to the Board of Directors of Xtant; “Annual Meeting” refers to our 2024 Annual Meeting of Stockholders; and “2023 Annual Report” or “2023 Annual Report to Stockholders” refer to our Annual Report on Form 10-K for the year ended December 31, 2023, being made available together with this proxy statement. Information on our website and any other website referenced herein is not incorporated by reference into, and does not constitute a part of, this proxy statement. ™ and ® denote trademarks and registered trademarks of Xtant Medical Holdings, Inc. or our affiliates, registered as indicated in the United States. All other trademarks and trade names referred to in this release are the property of their respective owners. iii XTANT MEDICAL HOLDINGS, INC. 664 Cruiser Lane Belgrade, Montana 59714 (406) 388-0480 PROXY TO BE HELD ON JULY 23, 2024 QUESTIONS AND ANSWERS ABOUT THE PROXY MATERIALS AND THE ANNUAL MEETING Q: Why am I receiving these materials? A: We are providing these proxy materials to you in connection with the solicitation of proxies by the Board of Directors (the “Board”) for our Annual Meeting, which will take place on July 23, 2024. As a stockholder of record, you are invited to attend the Annual Meeting and are entitled and requested to vote on the items of business described in this proxy statement. This proxy statement and accompanying proxy card (or voting instruction ca